14 February 2023 - - The "HIV Rapid Test Kits Market - Global Outlook & Forecast 2023-2028" report has been added to Dublin-based ResearchAndMarkets.com's offering.

The global HIV rapid test kits market size is expected to grow at a CAGR of 2.70% during 2022 to 2028.

In the US, HIV testing is vital and integral to HIV prevention and management.

The knowledge about HIV infection is increasing rapidly in the country, accelerating the high demand for HIV self-testing.

In recent years, the significant patient population in the country has gone through routine medical checkups, which includes HIV test. It increases the knowledge about HIV testing and care in the country and propels the market growth.

Human Immunodeficiency Virus is a viral infection that attacks the body's immune system and does not have effective care treatment across the world.

It leads to acquired immunodeficiency syndrome. Globally, more than 38.4m people are living with HIV infection, among which Africa accounted for the higher patient population.

HIV is one of the leading causes of death in the world. The Joint United Nations Programme on HIV/AIDS and WHO are two major health organizations working towards increasing awareness among people about HIV, HIV infection, and associated preventive measures.

These two organizations aim to reduce around 90% HIV burden of the world by 2030. Based on that, several countries joined these initiatives to improve their national HIV status.

HIV self-testing (HIVST) is one of the major strategies addressed by WHO and UNIAIDS to overcome the HIV burden.

These steps lead to an increase in demand for HIVST that directly impact the HIV rapid test kits market.

The rise of fourth-generation rapid test kits has become more popular in recent years. This technology is more accurate and reliable for screening the acute HIV presence in the sample.

The 4th generation HIV test easily detects HIV in lesser time and more accurately than other generation technologies.

Such factors allow individuals to get a cure sooner and potentially prevent the spread of infection to others.

One of the leading HIV rapid test kit market players, OraSure technologies, got approval for a home test kit known as "OraQuick In-Home HIV Test," which gives results in 20 to 40 minutes.

The UNAID and WHO are working together towards HIV prevention. Several strategic implementations are implemented worldwide to increase HIV self-testing (HIVST) and to understand the actual burden of HIV/AIDS globally.

Eastern and Southern Africa, and Western and Central Europe & North America are the regions that implemented several HIVST policies that deliver HIV rapid test kits market growth opportunities.

Due to the increasing acceptance of HIVST, the knowledge and awareness about HIV increased among the people, resulting in many people looking for easy HIV testing.

The COVID-19 pandemic led to several service disruptions in the supply of HIV diagnoses and treatments, which led to falling short of the UNAIDS 2030 target.

However, the COVID-19 pandemic accelerated the application of digital tools in health services.

The incorporation of digital tools gave a new paradigm in HIV care management. The application of digital tools in HIV management is increasing that expected to fuel the HIV rapid test kits market.

According to The Lancet research, the adoption and innovation of digital HIV self-testing tools have been increasing recently, and website-based innovations are becoming more popular.

Around 15m people acquired HIV in 2020. In 2022, more than 38 m people were expected to live with HIV.

This further results in increasing HIV preventive measures, which include increasing the number of people undergoing HIV tests through self-test kits.

In high-infection regions such as Africa, Europe, and Asian countries, the demand for HIV testing is increasing year by year, which drives the application rate of HIV rapid test kits and propels market growth.

Most countries are making significant progress in reducing the HIV burden with UNAIDS and WHO.

Globally, around 95% of people living with HIV are expected to be aware of their HIV status by 2025.

Further, the increasing prevalence of HIV, the awareness among HIV-infected and non-infected people in developed and developing countries is increasing rapidly.

In developed countries, HIV infection awareness increased through various government and health authorities' programs working as support to improve knowledge about HIV self-testing solutions.

The increasing access to HIV rapid test kits through health authorities and vendor activities and the acceptance of self-testing kits for HIV management are increasing simultaneously, fueling the HIV rapid test kits market growth.

The global HIV rapid test kits market based on technology is segmented into lateral flow immunoassay and immunofixation.

The lateral flow immunoassay segment accounted for a 78.25% market share in 2021.

A higher number of HIV rapid test kit products are available and approved by various health authorities in the market and are developed by the lateral flow immunoassay technology.

This technology delivers several advantaged and accurate results in HIV rapid testing. One of the major reasons for increasing preference towards the usage of HIV rapid test kits is their immediate results.

The quicker results will help healthcare professionals to make treatment plans in the market.

Quicker diagnosis of the disease will help the healthcare providers to safeguard the patients and to take enough preventive measures to reduce the spread of the disease in the market.

The blood sample type segment accounted for a higher 63.46% market share in the global HIV rapid test kits market and dominated the other segments.

Blood sample-based HIV rapid test kits are highly recommended by medical professionals due to their potential to carry HIV antibodies in high proportion.

In HIV testing, blood samples (plasma, serum, DBS) are highly preferred for HIV rapid testing. Blood samples carry higher concentrations of HIV antibodies than oral (saliva) samples.

These sample-based HIV rapid testing found antibodies using a drop of blood from the fingertip. In addition to the individuals, healthcare settings also use HIV rapid test kits that drive blood sample segmental growth.

In addition, HIV rapid test kits are distributed to patients through clinical laboratories, research centers, and community-based organizations.